{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T19:24:24Z","timestamp":1773689064551,"version":"3.50.1"},"reference-count":23,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"unspecified","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2022,5,14]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The COVID-19 pandemic has presented substantial new challenges to clinical and research teams. Our objective was to analyse the experience of investigators and research delivery staff regarding the research response to COVID-19 in order to identify these challenges as well as solutions for future pandemic planning.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a survey of diverse research staff involved in delivery of COVID-19 clinical trials across the UK. This was delivered online across centres linked to the NIHR Respiratory Translational Research Collaboration. Responses were analysed using a formal thematic analysis approach to identify common themes and recommendations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>83 survey participants from ten teaching hospitals provided 922 individual question responses. Respondents were involved in a range of research delivery roles but the largest cohort (60%) was study investigators. A wide range of research experiences were captured, including early and late phase trials. Responses were coded into overarching themes. Among common observations, complex protocols without adaptation to a pandemic were noted to have hampered recruitment. Recommendations included the need to develop and test pandemic-specific protocols, and make use of innovations in information technology. Research competition needs to be avoided and drug selection processes should be explicitly transparent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Delivery of clinical trials, particularly earlier phase trials, in a pandemic clinical environment is highly challenging, and was reactive rather than anticipatory. Future pandemic studies should be designed and tested in advance, making use of pragmatic study designs as far as possible and planning for integration between early and later phase trials and regulatory frameworks.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2022-001226","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T11:37:36Z","timestamp":1655206656000},"page":"e001226","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Large scale clinical trials: lessons from the COVID-19 pandemic"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct04381936","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04385095","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04390464","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04402866","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1828-0058","authenticated-orcid":false,"given":"Alex R","family":"Horsley","sequence":"first","affiliation":[{"name":"Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Pearmain","sequence":"additional","affiliation":[{"name":"Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK"},{"name":"Division of Diabetes, Endocrinology and Gastroenterology, The University of Manchester Faculty of Biology Medicine and Health, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Knight","sequence":"additional","affiliation":[{"name":"Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK"},{"name":"Department of Respiratory Medicine, Salford Royal NHS Foundation Trust, Salford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Schindler","sequence":"additional","affiliation":[{"name":"Institute of Continuing Education, University of Cambridge, Cambridge, UK"},{"name":"Department of Paediatrics, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Bennett","sequence":"additional","affiliation":[{"name":"Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca C","family":"Robey","sequence":"additional","affiliation":[{"name":"Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane C","family":"Davies","sequence":"additional","affiliation":[{"name":"National Heart & Lung Institute, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratko","family":"Djukanovi\u0107","sequence":"additional","affiliation":[{"name":"School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton School of Medicine, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam G","family":"Heaney","sequence":"additional","affiliation":[{"name":"Centre of Infection and Immunity, Queen's University Belfast, Belfast, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Hussell","sequence":"additional","affiliation":[{"name":"Manchester Centre for Infection and Inflammation Research, The University of Manchester Faculty of Biology Medicine and Health, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-7183","authenticated-orcid":false,"given":"Stefan J","family":"Marciniak","sequence":"additional","affiliation":[{"name":"Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK"},{"name":"Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorcan P","family":"McGarvey","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Porter","sequence":"additional","affiliation":[{"name":"Centre for Inflammation & Tissue Repair, University College London Division of Medicine, London, UK"},{"name":"Interstitial Lung Disease Service, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Medicine, University of Southampton School of Medicine, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5803-5121","authenticated-orcid":false,"given":"Chris","family":"Brightling","sequence":"additional","affiliation":[{"name":"Institute of Lung Health, University of Leicester, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Pei","family":"Ho","sequence":"additional","affiliation":[{"name":"MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford, UK"},{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"2025083109381149000_9.1.e001226.1","unstructured":"Guan WJ , ZY N , Hu Y . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020."},{"key":"2025083109381149000_9.1.e001226.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"2025083109381149000_9.1.e001226.3","unstructured":"Organisation WH . Timeline of WHO\u2019s response to COVID-19, 2020. Available: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/interactive-timeline#"},{"key":"2025083109381149000_9.1.e001226.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.12.016"},{"key":"2025083109381149000_9.1.e001226.5","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202003-192SD"},{"key":"2025083109381149000_9.1.e001226.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1985"},{"key":"2025083109381149000_9.1.e001226.7","unstructured":"Collins S , Self W , Mebazza A . Lessons from COVID-19 for acute care research in a Post-Pandemic world. Lancet Respiratory Medicine 2022."},{"key":"2025083109381149000_9.1.e001226.8","unstructured":"Braun V , Clarke V , Boulton E . The online survey as a qualitative research tool. International Journal of Social Research Methodology 2020:1\u201314."},{"key":"2025083109381149000_9.1.e001226.9","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2025083109381149000_9.1.e001226.10","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"},{"key":"2025083109381149000_9.1.e001226.11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/ACM.0000000000002088","article-title":"Why open-ended survey questions are unlikely to support rigorous qualitative insights","volume":"93","author":"LaDonna","year":"2018","journal-title":"Acad Med"},{"key":"2025083109381149000_9.1.e001226.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32013-4"},{"key":"2025083109381149000_9.1.e001226.13","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (recovery): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"2025083109381149000_9.1.e001226.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436"},{"key":"2025083109381149000_9.1.e001226.15","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","article-title":"Effect of hydroxychloroquine in hospitalized patients with Covid-19","volume":"383","author":"Horby","year":"2020","journal-title":"N Engl J Med"},{"key":"2025083109381149000_9.1.e001226.16","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-020-04584-9","article-title":"Accord: a multicentre, seamless, phase 2 adaptive randomisation platform study to assess the efficacy and safety of multiple candidate agents for the treatment of COVID-19 in hospitalised patients: a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Wilkinson","year":"2020","journal-title":"Trials"},{"key":"2025083109381149000_9.1.e001226.17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S2213-2600(21)00460-4","article-title":"Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (catalyst): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial","volume":"10","author":"Fisher","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2025083109381149000_9.1.e001226.18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-2600(20)30511-7","article-title":"Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"Monk","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2025083109381149000_9.1.e001226.19","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-020-04618-2","article-title":"muLTi-Arm therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): a structured summary of a study protocol for a randomized controlled trial","volume":"21","author":"Lu","year":"2020","journal-title":"Trials"},{"key":"2025083109381149000_9.1.e001226.20","unstructured":"Health and Social Care aSaTC . Coronavirus: lessons learned to date. London: House of Commons, 2021."},{"key":"2025083109381149000_9.1.e001226.21","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/cts.13104","article-title":"Accelerating vaccine trial conduct in a pandemic with a hot spot-based inclusion strategy using trial and epidemic simulation","volume":"14","author":"van der Plas","year":"2021","journal-title":"Clin Transl Sci"},{"key":"2025083109381149000_9.1.e001226.22","article-title":"Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (recovery): a randomised, controlled, open-label, platform trial","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"2025083109381149000_9.1.e001226.23","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.7861\/fhj.2021-0083","article-title":"Making trials part of good clinical care: lessons from the recovery trial","volume":"8","author":"Pessoa-Amorim","year":"2021","journal-title":"Future Healthc J"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2022-001226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T16:38:19Z","timestamp":1756658299000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2022-001226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,6,14]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/bmjresp-2022-001226"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2022-001226","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}